NCT04980989

Follow-up of Early Breast Cancer (BC) Patients by Telephone or Mobile Software

Completed NA Last updated 28 July 2021

What this trial tests

NA trial testing Mobile software for follow-up of early breast cancer in Breast Cancer, Early-Onset in 765 participants. Completed in 15 June 2021.

Timeline

15 June 2015

Primary endpoint
15 June 2021

15 June 2021

Quick facts

Lead sponsor	Helsinki University Central Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	health services research
Enrollment	765
Start date	15 June 2015
Primary completion	15 June 2021
Estimated completion	15 June 2021

Drugs / interventions tested

• Mobile software for follow-up of early breast cancer

Conditions studied

• Breast Cancer, Early-Onset — all drugs for Breast Cancer, Early-Onset →

Sponsor

Helsinki University Central Hospital

Who can join

18 and older, any sex, with Breast Cancer, Early-Onset. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with early breast cancer were randomized at the final visit of adjuvant radiotherapy to surveillance by phone calls or by mobile Noona software. After six months the groups were crossed over to the other arm. At 12 months the patients were asked their preference which was the primary end-point. At baseline, 6 months and 12 months the patients answered the other questionnaires.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. Digital solution in the follow-up of early breast cancer a randomized study.
   Mattson J, Peltola M, Poikonen-Saksela P, Hermanson T, et al · · 2023 · cited 3× · PMID 37190970 · DOI 10.1080/0284186x.2023.2212409
2. Comparing the Costs of Surveillance of Early-Stage Breast Cancer by Digital or Traditional Follow-Up Methods: Randomized Crossover Study.
   Peltola M, Blomqvist C, Färkkilä N, Poikonen-Saksela P, et al · · 2025 · PMID 40838960 · DOI 10.2196/58113